José María Zapico

Dr. José María Zapico

Departamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, 28925 Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Loganathan RangasamyLoganathan Rangasamy
Loganathan Rangasamy
BGBruno Di Geronimo
Bruno Di Geronimo
Irene Ortin RemonIrene Ortin Remon
Irene Ortin Remon
CCClaire Coderch
Claire Coderch
JZJosé María Zapico
José María Zapico
Beatriz de Pascual-TeresaBeatriz de Pascual-Teresa
Beatriz de Pascual-Teresa
Matrix metalloproteinases (MMPs) are a family of zinc- and calcium-dependent endopeptidases which are secreted or anchored in the cell membrane and are capable of degrading the multiple components of the extracellular matrix (ECM). MMPs are frequently overexpressed or highly activated in numerous human diseases. Owing to the important role of MMPs in human diseases, many MMP inhibitors (MMPIs) have been developed as novel therapeutics, and some of them have entered clinical trials. However, so far, only one MMPI (doxycycline) has been approved by the FDA. Therefore, the evaluation of the activity of a specific subset of MMPs in human diseases using clinically relevant imaging techniques would be a powerful tool for the early diagnosis and assessment of the efficacy of therapy. In recent years, numerous MMPIs labeled imaging agents have emerged. This article begins by providing an overview of the MMP subfamily and its structure and function. The latest advances in the design of subtype selective MMPIs and their biological evaluation are then summarized. Subsequently, the potential use of MMPI-labeled diagnostic agents in clinical imaging techniques are discussed, including positron emission tomography (PET), single-photon emission computed tomography (SPECT) and optical imaging (OI). Finally, this article concludes with future perspectives and clinical utility.

25 March 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RMRegina Martínez
Regina Martínez
BGBruno Di Geronimo
Bruno Di Geronimo
MPMiryam Pastor
Miryam Pastor
JZJosé María Zapico
José María Zapico
CCClaire Coderch
Claire Coderch
Beatriz de Pascual-TeresaBeatriz de Pascual-Teresa
Beatriz de Pascual-Teresa
The design of multitarget drugs (MTDs) has become an innovative approach for the search of effective treatments in complex diseases such as cancer. In this work, we communicate our efforts in the design of multi-targeting histone deacetylase (HDAC) and protein kinase CK2 inhibitors as a novel therapeutic strategy against cancer. Using tetrabromobenzotriazole (TBB) and 2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole (DMAT) as scaffolds for CK2 inhibition, and a hydroxamate to coordinate the zinc atom present in the active site of HDAC (zinc binding group, ZBG), new multitarget inhibitors have been designed and synthesized. According to the in vitro assays, N-Hydroxy-6-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)hexanamide (11b) is the most interesting compound, with IC50 values of 0.66; 1.46 and 3.67 µM. for HDAC6; HDAC1 and CK2; respectively. Cellular assays on different cancer cell lines rendered promising results for N-Hydroxy-8-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)octanamide (11d). This inhibitor presented the highest cytotoxic activity, proapoptotic capability, and the best mitochondria-targeting and multidrug-circumventing properties, thus being the most promising drug candidate for further in vivo studies.

1 December 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
CCClaire Coderch
Claire Coderch
MCMaría Díaz de Cerio
María Díaz de Cerio
JZJosé María Zapico
José María Zapico
RPRafael Peáez
Rafael Peáez
ILIgnacio M. Larrayoz
Ignacio M. Larrayoz
Beatriz de Pascual-TeresaBeatriz de Pascual-Teresa
Beatriz de Pascual-Teresa

Verified
Journal Article
Open access
PDF file
JZJosé María Zapico
José María Zapico
LALourdes Acosta
Lourdes Acosta
MPMiryam Pastor
Miryam Pastor
Loganathan RangasamyLoganathan Rangasamy
Loganathan Rangasamy
LCLaura Márquez Cantudo
Laura Márquez Cantudo
ARAna Ramos
Ana Ramos
Osteoarthritis is a degenerative disease, often resulting in chronic joint pain and commonly affecting elderly people. Current treatments with anti-inflammatory drugs are palliative, making the discovery of new treatments necessary. The inhibition of matrix metalloproteinase MMP-13 is a validated strategy to prevent the progression of this common joint disorder. We recently described polybrominated benzotriazole derivatives with nanomolar inhibitory activity and a promising selectivity profile against this collagenase. In this work, we have extended the study in order to explore the influence of bromine atoms and the nature of the S1′ heterocyclic interacting moiety on the solubility/selectivity balance of this type of compound. Drug target interactions have been assessed through a combination of molecular modeling studies and NMR experiments. Compound 9a has been identified as a water-soluble and highly potent inhibitor with activity in MG-63 human osteosarcoma cells.

28 April 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MZMaría Rodríguez Zapata
María Rodríguez Zapata
MGMilagros Galán-Llario
Milagros Galán-Llario
HCHéctor Cañeque-Rufo
Héctor Cañeque-Rufo
JSJulio Sevillano
Julio Sevillano
MSMaría Gracia Sánchez-Alonso
María Gracia Sánchez-Alonso
EGEsther Gramage
Esther Gramage
Binge drinking during adolescence increases the risk of alcohol use disorder, possibly by involving alterations of neuroimmune responses. Pleiotrophin (PTN) is a cytokine that inhibits Receptor Protein Tyrosine Phosphatase (RPTP) β/ζ. PTN and MY10, an RPTPβ/ζ pharmacological inhibitor, modulate ethanol behavioral and microglial responses in adult mice. Now, to study the contribution of endogenous PTN and the implication of its receptor RPTPβ/ζ in the neuroinflammatory response in the prefrontal cortex (PFC) after acute ethanol exposure in adolescence, we used MY10 (60 mg/kg) treatment and mice with transgenic PTN overexpression in the brain. Cytokine levels by X-MAP technology and gene expression of neuroinflammatory markers were determined 18 h after ethanol administration (6 g/kg) and compared with determinations performed 18 h after LPS administration (5 g/kg). Our data indicate that Ccl2, Il6, and Tnfa play important roles as mediators of PTN modulatory actions on the effects of ethanol in the adolescent PFC. The data suggest PTN and RPTPβ/ζ as targets to differentially modulate neuroinflammation in different contexts. In this regard, we identified for the first time important sex differences that affect the ability of the PTN/RPTPβ/ζ signaling pathway to modulate ethanol and LPS actions in the adolescent mouse brain.

25 January 2023 in Neuropharmacology
Verified
Journal Article
Open access
MGMilagros Galán-Llario
Milagros Galán-Llario
MZMaría Rodríguez Zapata
María Rodríguez Zapata
TFTeresa Fontán-Baselga
Teresa Fontán-Baselga
EGEsther Gramage
Esther Gramage
MVMarta Vicente-Rodríguez
Marta Vicente-Rodríguez
Gonzalo HerradonGonzalo Herradon
Gonzalo Herradon
Pleiotrophin (PTN) is a cytokine that modulates ethanol drinking and reward and regulates glial responses in different contexts. PTN is an inhibitor of Receptor Protein Tyrosine Phosphatase (RPTP) β/ζ. Inhibition of RPTPβ/ζ reduces binge-like drinking in adult male mice. Whether inhibition of RPTPβ/ζ is effective in reducing ethanol consumption during adolescence and in both sexes remained to be studied. In this work, male and female adolescent mice underwent an intermittent access to ethanol (IAE) 2-bottle choice protocol. Treatment with MY10 (60 mg/kg, i.g.), a small-molecule RPTPβ/ζ inhibitor, reduced chronic 3-week ethanol consumption only in male mice. We detected an ethanol-induced overall decrease in hippocampal GFAPir and Iba1ir, independently of the treatment received, suggesting that RPTPβ/ζ is not key in the regulation of IAE-induced glial responses. However, we found a significant negative correlation between the size of microglial cells and the number of hippocampal neuronal progenitors only in male mice after IAE. This correlation was disrupted by treatment with MY10 before each drinking session, which may be related to the ability of MY10 to regulate the intensity of the perineuronal nets (PNNs) in the hippocampus in a sex-dependent manner. The data show for the first time that inhibition of RPTPβ/ζ reduces chronic voluntary ethanol consumption in adolescent mice in a sex-dependent manner. In addition, we show evidence for sex-specific differences in the effects of IAE on glial responses and hippocampal neurogenesis, which may be related to different actions of the RPTPβ/ζ signalling pathway in the brains of male and female mice.